EXI1:F:F-iShares SLI UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 138.3

Change

-0.48 (-0.35)%

Market Cap

USD 0.37B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.16 (+0.60%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.36 (+0.70%)

USD 117.56B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.38 (+0.68%)

USD 97.02B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 89.53B
EUNL:F iShares Core MSCI World UCITS ..

+0.25 (+0.26%)

USD 72.04B
FRCJ:F UBS MSCI Japan Socially Respon..

+0.17 (+0.74%)

USD 71.25B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 58.22B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.90 (+1.25%)

USD 56.96B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.04 (-0.04%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

-0.13 (-0.13%)

USD 51.63B

ETFs Containing EXI1:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.85% 52% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.85% 50% F 53% F
Trailing 12 Months  
Capital Gain 10.76% 57% F 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.76% 55% F 57% F
Trailing 5 Years  
Capital Gain 46.30% 71% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 46.30% 71% C- 57% F
Average Annual (5 Year Horizon)  
Capital Gain 8.52% 73% C 70% C-
Dividend Return 8.52% 72% C 63% D
Total Return N/A 25% F 48% F
Risk Return Profile  
Volatility (Standard Deviation) 12.08% 54% F 81% B-
Risk Adjusted Return 70.58% 88% B+ 90% A-
Market Capitalization 0.37B 54% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.